Fast 3D Optical Mammography using ICG Dynamics for Reader-Independent Lesion Differentiation

Similar documents
INTRODUCTION. Breast cancer is an epidemic that affects more than 200,000 new patients each year. With greater than

Contrast-enhanced diffuse optical tomography of brain perfusion in humans using ICG

SOORYA PETER IVEN JOSE CHRIST UNIVERSITY FACULTY OF ENGINEERING. Excerpt from the Proceedings of the 2014 COMSOL Conference in Bangalore

Armed Forces Institute of Pathology.

OPTO-ACOUSTIC BREAST IMAGING

University of Washington Radiology Review Course: Strange and Specific Diagnoses. Case #1

RSNA, /radiol Appendix E1. Methods

Clinical feasibility of co-registered opto-acoustic and ultrasonic imaging for differentiation of breast tumors

Contrast-enhanced Breast MRI RSSA 2013

In vivo optical imaging : revealing endogeneous optical contrast at depth

Evolution of diagnostic ultrasound systems Current achievements in breast ultrasound

Compressive Re-Sampling for Speckle Reduction in Medical Ultrasound

Optical biomarkers for breast cancer derived from dynamic diffuse optical tomography

Ultrasound-Guided Optical Tomographic Imaging of Malignant and Benign Breast Lesions: Initial Clinical Results of 19 Cases 1

Non-mass Enhancement on Breast MRI. Aditi A. Desai, MD Margaret Ann Mays, MD

OPTO-ACOUSTIC BREAST IMAGING

Here are examples of bilateral analog mammograms from the same patient including CC and MLO projections.

The latest developments - Automated Breast Volume Scanning. Dr. med. M. Golatta

Evaluation of BI-RADS 3 lesions in women with a high risk of hereditary breast cancer.

Lesion Imaging Characteristics Mass, Favoring Benign Circumscribed Margins Intramammary Lymph Node

Breast Cancer Diagnosis, Treatment and Follow-up

CT Laser Mammography CTLM

Pitfalls and Limitations of Breast MRI. Susan Orel Roth, MD Professor of Radiology University of Pennsylvania

CONTENTS NOTE TO THE READER...1 LIST OF PARTICIPANTS...3

Breast Cancer Imaging

Pharmacokinetic evaluation of DCIS

Optical Imaging: Technology and Applications for Radiology

Leonard M. Glassman MD

Updates in Mammography. Dr. Yang Faridah A. Aziz Department of Biomedical Imaging University Malaya Medical Centre

Near-infrared imaging of the human breast: complementing hemoglobin concentration maps with oxygenation images

The role of apparent diffusion coefficient (ADC) and relative ADC in the evaluation of breast masses

Mammographic imaging of nonpalpable breast lesions. Malai Muttarak, MD Department of Radiology Chiang Mai University Chiang Mai, Thailand

Multimodal Spectroscopic Tissue Scanner for diagnosis of ex vivo surgical specimens

Computer Aided Detection (CAD) for Breast MRI

MRI-Based Biomarkers of Therapeutic Response in Triple-Negative Breast Cancer

Since its introduction in 2000, digital mammography has become

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY

Leonard M. Glassman MD Analysis of Breast Calcifications

Tomosynthesis and breast imaging update. Dr Michael J Michell Consultant Radiologist King's College Hospital NHS Foundation Trust

National Diagnostic Imaging Symposium 2013 SAM - Breast MRI 1

Diffuse optical tomography of the breast: preliminary findings of a new prototype and comparison with magnetic resonance imaging

Optical Intra-operative Assessment of Breast Tumor Margins

Emerging Techniques in Breast Imaging: Contrast-Enhanced Mammography and Fast MRI

Radiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant

Radiologic and pathologic correlation of non-mass like breast lesions on US and MRI: Benign, high risk, versus malignant

Using Near-Infrared Light To Detect Breast Cancer

Diffusion Weighted Imaging in Prostate Cancer

Using lesion washout volume fraction as a biomarker to improve suspicious breast lesion characterization

Index. Surg Oncol Clin N Am 16 (2007) Note: Page numbers of article titles are in boldface type.

Armed Forces Institute of Pathology.

Contralateral Prophylactic Mastectomy with Immediate Reconstruction: Added Benefits, Added Risks

The early detection programme for breast cancer

Screening Mammograms: Questions and Answers

Financial Disclosures

Computer-aided detection (CAD) for breast MRI: evaluation of efficacy at 3.0 T

Contrast-Enhanced Digital Mammography

Large health system benefits from multiple scanners for breast MRI

Breast Cancer Screening Clinical Practice Guideline. Kaiser Permanente National Breast Cancer Screening Guideline Development Team

Current Imaging Diagnosis of the Breast Tumors

Categorical Classification of Spiculated Mass on Breast MRI

PAAF vs Core Biopsy en Lesiones Mamarias Case #1

Does elastography change the indication to biopsy? IBDC

Imaging in breast cancer. Mammography and Ultrasound Donya Farrokh.MD Radiologist Mashhad University of Medical Since

Screening mammograms in women <50 years of age: Low risk is NOT protective

BREAST CANCER SCREENING IS A CHOICE

arxiv: v2 [cs.cv] 8 Mar 2018

EARLY DETECTION: MAMMOGRAPHY AND SONOGRAPHY

Certified Breast Care Nurse (CBCN ) Test Content Outline (Effective 2018)

Hybrid Brain-Computer Interfaces

Current Status of Supplementary Screening With Breast Ultrasound

Rare Breast Tumours. 1. Breast Tumours. 1.1 General Results. 1.2 Incidence

WHICH INDICATION FOR BREAST MRI?

CURRICULUM FOR THE BREAST PATHOLOGY ROTATION UNIVERSITY OF FLORIDA DEPARTMENT OF PATHOLOGY

Interpretation of Breast Pathology in the Era of Minimally Invasive Procedures

Classifying Breast Masses in Volumetric Whole Breast Ultrasound Data: A 2.5-Dimensional Approach

Mammography and Other Screening Tests. for Breast Problems

Detailed Program of the second BREAST IMAGING AND INTERVENTIONS PROGRAM am am : Clinician s requirements from breast imaging

Breast cancer tumor size: Correlation between MRI and histopathology

Innovations in Ultrasound & Breast Cancer Imaging

Feasibility of MRI-guided large-core-needle biopsy of suspiscious breast lesions at 3T

LYMPHATIC DRAINAGE AXILLARY (MOSTLY) INTERNAL MAMMARY SUPRACLAVICULAR

Breast Cancer Screening with Mammography

Mammographic evaluation of palpable breast masses with pathological correlation: a tertiary care centre study in Nepal

Time domain diffuse optical imaging and spectroscopy for biomedical diagnostics. Rinaldo Cubeddu

MRI BI-RADS: How to make it out?

Mammography Education, Inc.

Automatic Computer Aided Diagnosis of Breast Cancer in Dynamic Contrast Enhanced Magnetic Resonance Images. Hongbo Wu

Presented by: Lillian Erdahl, MD

Public Health Agency NORTHERN IRELAND BREAST SCREENING PROGRAMME ANNUAL REPORT & STATISTICAL BULLETIN QUALITY ASSURANCE REFERENCE CENTRE

Educational Goals and Objectives for Rotations on: Breast, Wound and Plastic Surgery

Concurrent near-infrared spectroscopy (NIRS) and functional magnetic resonance imaging (fmri) of the brain

SFMC Breast Cancer Site Study: 2011

New developments in Non-invasive Biomedical Optics

Breast Tomosynthesis. What is breast tomosynthesis?

Spectrum of findings of sclerosing adenosis at breast MRI.

Medical Policy An independent licensee of the Blue Cross Blue Shield Association

Can magnetic resonance imaging obviate the need for biopsy for microcalcifications?

Mammography Education, Inc.

Perfusion Physics. ICMRI2018 March 29-31, 2018 Grand Hilton Hotel, Seoul, Korea. Asian Forum Ⅱ: Perfusion MRI SY24-1.

Transcription:

Fast 3D Optical Mammography using ICG Dynamics for Reader-Independent Lesion Differentiation Sophie Piper 1 P.Schneider 1, N. Volkwein 1, N.Schreiter 1, C.H. Schmitz 1,2, A.Poellinger 1 1 Charité University Medicine Berlin 2 NIRx Medizintechnik GmbH, Berlin OSA Biomed 28 April - 2 May 2012, Miami, Florida

Introduction Why alternatives to the gold standard of X-ray mammography? Very reader- dependent diagnosis Need for a better differentiation between malignant and benign lesions Non-invasive (radioation free) alternative for breast cancer screening and monitoring preferred General Benefits of optical mammography: Non- invasive, no radiation Tomographic imaging Functional information Dynamic imaging possible - Ability to track changes of internal parameters (Hb, HbO etc) or extrinsic contrast agents over time

Motivation Fast 3D Diffuse Optical Imaging (SR >1 Hz): Early Bolus kinetics can now be adequately imaged 10-4 bolus injection Measuring early bolus kinetics over the entire breast can help differentiating between malignant and benign or healthy breast tissue

Fast 3D Diffuse Optical Imaging System Optical Mammography with 1.9 Hz Temporal Resolution - DYNOT 232 optical tomography system (NIRx Medizintechnik, Berlin, Germany//NY, USA) Study - 31 co-located Design: source/detector fibers: 961 S/D, 760 and 830nm - 22 ~ 2 patients: complete14 volume malignant scans + 8 per benign second lesions, 3 controls - Reconstruction 25mg ICG bolus(nirx within NAVI 5-10 Software) sec of relative absorption changes in each of 2243 FEM nodes/ 14000 isometric voxel P. Schneider C. H. Schmitz et al. et Rofo,183(10):956-63 al., Rev. Sci. Instrum. (2011). (2002)

Bolus Peak Mapping 10-4 Time-to-Peak Peak Amplitude relative absorption changes [-] fast slow Timeframes 1 frame = 0.5 s

Reader- dependent visual inspection Results healthy non-cancer tumor tumor In general: A priori information about the localization of the lesion and an experience reader is necessary.

Peak-Time grouped Amplitude (PTA) normalized relative absorption changes [%] Mean time courses of voxel with equal peak time 200 150 100 50 0-10 0 10 20 30 Time [sec] Case1: 53y, 33mm invasive ductal carcinoma malignant 0 10 TTP [sec] 200 150 100 50 0 benign -10 0 10 20 30 40 Time [sec] Case2: 22y, 22mm fibroadenoma 0 10 TTP [sec] TTP =0.5sec TTP =1sec TTP =1.5sec TTP =2sec TTP =5sec TTP =7.5sec mean breast

Mean PTA-curves over all patients ** Mean peak time grouped amplitudes (PTA) over time 2 Mean Peak Time Grouped Amplitude [%] 100 50 BENIGN (8) MALIGNANT (14) SMD Maximum SMD 1 0 Standardized Mean Difference [a.u.] 0 2 4 6 8 10 12-1 Time To Peak [sec] Significant Difference of PTA at TTP= 1.5sec between the malignant and benign lesions (Wilcoxen test, p=0.0015)

Reader independent Classification Approach Mean peak time grouped amplitudes (PTA) over time 2 1 Mirrored ROC curve Mean Peak Time Grouped Amplitude [% ] 100 50 BENIGN (8) MALIGNANT (14) SMD Classifying Threshold 0 2 4 Time To Peak 6 [sec] 8 10 12-1 1 0 Standardized Mean Difference [a.u.] True positive rate (Sensitivity) 0.8 0.6 0.4 0.2 AUC=0.92 0 0 0.2 0.4 0.6 0.8 1 True negative rate (Specificity) Decision Boundary for Reader Independent Classification: PTA = 84.4% of the mean bolus signal P. Schneider et al. Rofo,183(10):956-63 (2011).

Classification Rates for 22 patients Malignant, mean lesion size (range) Detection Rate Benign, mean lesion size (range) Detection Rate Invasive ductal carcinoma, 29mm (8-51mm) 8 / 9 Fibro-cystic mastopathy, 11mm 1 / 1 Invasive lobular carcinoma, 25mm 1 / 1 Fibroadenoma, 24mm (10-51mm) 5/ 6 Invasive lobular ductal carcinoma, 17mm 0/1 Pseudoangiomatous stromalhyperplasia (PASH), (44mm) 1/ 1 Metaplastic carcinoma, 28mm (19-37mm) 2 / 2 Ductal carcinoma in situ, 80mm 1 / 1 Sum 12 / 14 Sum 7/8 P. Schneider et al. Rofo,183(10):956-63 (2011).

Summary High-frame rate DOT allows to adequately image early bolus kinetics. Extracting Peak time grouped amplitudes out of those kinetic curves can be used for an automatic differentiation between malignant and benign breast lesions. Mean peak time grouped amplitudes (PTA) over time 2 Mean Peak Time Grouped Amplitude [%] 100 50 BENIGN (8) MALIGNANT (14) SMD Classifying Threshold 0 2 4 Time To Peak 6 [sec] 8 10 12-1 1 0 Standardized Mean Difference [a.u.] Published: P. Schneider et al., Fast 3D Near-Infrared Breast Imaging Using Indocyanine Green for Detection and Characterization of Breast Lesions, Rofo,183(10):956-63(2011).

Outlook To further investigate the robustness of the suggested approach more patient data are needed. Cooperation with the Machine Learning Group of the Technical University Berlin Classifying PTA values at TTP=1.5 sec : mean loss: 0.19±0.02 Classifying PTA curves ( TTP: 0 40sec) : mean loss: 0.10±0.03

Acknowledgements Special thanks to my colleagues and cooperators: Dept. of Radiology Charité University Medicine Berlin P. Schneider, N. Volkwein, N. Schreiter, A. Poellinger NIRx Medizintechnik GmbH Berlin Berlin NeuroImaging Center, Charite C.H. Schmitz Machine Learning Group Technical University Berlin S. Fazli B. Blankertz

Thank you for your attention!